Metraipolis › archive › dc_ff757934f237
Cycloastragenol Provides Pharmacokinetic Advantages over Astragaloside IV with Enhanced Cochlear Exposure and Protection Against Age-Associated Hearing… — Europe PMC PMID:42654154
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42654154
- DOI
- 10.3390/pharmaceutics18081037
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T14:17:50.185Z
- SHA-256 of the archived text
f10c809bbfdde361641fa46311d27e5eaaf5e5eed246780e1e0299d2bebf2d9c- Stable URL of this page
https://metraipolis.com/documento/dc_ff757934f237
How to cite
Cycloastragenol Provides Pharmacokinetic Advantages over Astragaloside IV with Enhanced Cochlear Exposure and Protection Against Age-Associated Hearing… — Europe PMC PMID:42654154 — Europe PMC (en), https://europepmc.org/article/MED/42654154 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ff757934f237 (Metraipolis archive dc_ff757934f237, sha256 f10c809bbfdde361641fa46311d27e5eaaf5e5eed246780e1e0299d2bebf2d9c)
BibTeX
@misc{dcff757934f237,
title = {Cycloastragenol Provides Pharmacokinetic Advantages over Astragaloside IV with Enhanced Cochlear Exposure and Protection Against Age-Associated Hearing… — Europe PMC PMID:42654154},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42654154},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ff757934f237; sha256 f10c809bbfdde361641fa46311d27e5eaaf5e5eed246780e1e0299d2bebf2d9c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42654154. Agents can read the archived copy with the MCP tool read_document.